PrimeRFP SCOUT · Federal Contract Profile

Enalare Therapeutics (MDJFW877BCV6)Federal contracts

Enalare Therapeutics holds $6.3M in federal volume across 1 award actions, with 100% at Department of Health and Human Services (HHS). Primary work: Research And Development In The (100% prime). Obligations are up 960% year over year.

$6.3M
Federal Volume
0
Recompetes (24mo)
HHS
Top Agency · 100% firm-wide
1
Award Actions

Choose one — this changes what we ask next

Score my firm against Enalare Therapeutics

Email me when a Enalare Therapeutics recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026

Why are you looking at Enalare Therapeutics?

Score my firm against Enalare Therapeutics

Email me when a Enalare Therapeutics recompete window opens.

What they do

Capability

Service lines

RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

Work mix: 100% prime · 0% sub · primary NAICS 541714 / PSC AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT

Where they win

Sole agency
Sole agency: Department of Health and Human Services (HHS)

Recompete exposure: None

SCOUT does not currently show incumbent recompetes for Enalare Therapeutics in the next 24 months.

Recompete exposure & trajectory

Recompete exposure

None

SCOUT does not currently show incumbent recompetes for Enalare Therapeutics in the next 24 months.

The rest of this firm’s 24-month recompete book is not on this page yet. Open the live SCOUT company view.

Trajectory
Expanding+960% YoYFY2024 vs FY2023
'23
'24
With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…
Peter Lierni, Solutioneering
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Enalare Therapeutics hold?

Enalare Therapeutics (UEI MDJFW877BCV6) shows $6.3M across 1 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Enalare Therapeutics have?

Enalare Therapeutics shows $6.3M across 1 award actions.

Which agencies does Enalare Therapeutics work with?

Enalare Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).

What is the UEI for Enalare Therapeutics?

The Unique Entity ID (UEI) for Enalare Therapeutics is MDJFW877BCV6.

Seen enough? Run one full capture cycle on Enalare Therapeutics — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026. · NJ
primerfp.com/intel/company/enalare-therapeutics-inc